bims-glucamGlutamine cancer metabolism
This report is maintained by Sreeparna Banerjee, Middle East Technical University. It brings out roughly 15 papers per issue.
0000‒00‒00
 Sign up
2026–09–27
2026–09–20
0000‒00‒00
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
2026–09–13
2026–09–06
2026–08–30
2026–08–23
2026–08–16
2026–08–09
2026–08–02
2026–07–26
2026–07–19
2026–07–12
2026–07–05
2026–06–28
2026–06–21
2026–06–14
2026–06–07
2026–05–31
2026–05–24
2026–05–17
2026–05–10
2026–05–03
2026–04–26
2026–04–19
2026–04–12
2026–04–05
2026–03–29
2026–03–22
2026–03–15
2026–03–08
2026–03–01
2026–02–22
2026–02–15
2026–02–08
2026–02–01
2026–01–25
2026–01–18
2026–01–11
2026–01–04
2025–12–28
2025–12–21
2025–12–14
2025–12–07
2025–11–30
2025–11–23
2025–11–16
2025–11–09
2025–11–02
2025–10–26
2025–10–19
2025–10–12
2025–10–05
2025–09–28
2025–09–21
2025–09–14
2025–09–07
2025–08–31
2025–08–24
2025–08–17
2025–08–10
2025–08–03
2025–07–27
2025–07–20
2025–07–13
2025–07–06
2025–06–29
2025–06–22
2025–06–15
2025–06–08
2025–06–01
2025–05–25
2025–05–18
2025–05–11
2025–05–04
2025–04–27
2025–04–20
2025–04–13
2025–04–06
2025–03–30
2025–03–23
2025–03–16
2025–03–09
2025–03–02
2025–02–23
2025–02–16
2025–02–09
2025–02–02
2025–01–26
2025–01–19
2025–01–12
2025–01–05
2024–12–29
2024–12–22
2024–12–15
2024–12–08
2024–12–01
2024–11–24
2024–11–17
2024–11–10
2024–11–03
2024–10–27
2024–10–20
2024–10–13
2024–10–06
2024–09–29
2024–09–22
2024–09–15
2024–09–08
2024–09–01
2024–08–25
2024–08–18
2024–08–11
2024–08–04
2024–07–28
2024–07–21
2024–07–14
2024–07–07
2024–06–30
2024–06–23
2024–06–16
2024–06–09
2024–06–02
2024–05–26
2024–05–19
2024–05–12
2024–05–05
2024–04–28
2024–04–21
2024–04–14
2024–04–07
2024–03–31
2024–03–24
2024–03–17
2024–03–10
2024–03–03
2024–02–25
2024–02–18
2024–02–11
2024–02–04
2024–01–28
2024–01–21
2024–01–14
2024–01–07
2023–12–31
2023–12–24
2023–12–17
2023–12–10
2023–12–03
2023–11–26
2023–11–19
2023–11–12
2023–11–05
2023–10–29
2023–10–22
2023–10–15
2023–10–08
2023–10–01
2023–09–24
2023–09–17
2023–09–10
2023–09–03
2023–08–27
2023–08–20
2023–08–13
2023–08–06
2023–07–30
2023–07–23
2023–07–16
2023–07–09
2023–07–02
2023–06–25
2023–06–18
2023–06–11
2023–06–04
2023–05–28
2023–05–21
2023–05–14
2023–05–07
2023–04–30
2023–04–23
2023–04–16
2023–04–09
2023–04–02
2023–03–26
2023–03–19
2023–03–12
2023–03–05
2023–02–26
2023–02–19
2023–02–12
2023–02–05
2023–01–29
2023–01–22
2023–01–15
2023–01–08
2023–01–01
2022–12–25
2022–12–18
2022–12–11
2022–12–04
2022–11–27
2022–11–20
2022–11–13
2022–11–06
2022–10–30
2022–10–23
2022–10–16
2022–10–09
2022–10–02
2022–09–25
2022–09–18
2022–09–11
2022–09–04
2022–08–28
2022–08–21
2022–08–14
2022–08–07
2022–07–31
2022–07–24
2022–07–17
2022–07–10
2022–07–03
2022–06–26
2022–06–19
2022–06–12
2022–06–05
2022–05–29
2022–05–22
2022–05–15
2022–05–08
2022–05–01
2022–04–24
2022–04–17
2022–04–10
2022–04–03
2022–03–27
2022–03–20
2022–03–13
2022–03–06
2022–02–27
2022–02–20
2022–02–13
2022–02–06
2022–01–30
2022–01–23
2022–01–16
2022–01–09
2022–01–02
2021–12–26
2021–12–19
2021–12–12
2021–12–05
2021–11–28
2021–11–21
2021–11–14
2021–11–07
2021–10–31
2021–10–24
2021–10–17
2021–10–10
2021–10–03
2021–09–26
2021–09–19
2021–09–12
2021–09–05
2021–08–29
2021–08–22
2021–08–15
2021–08–08
2021–08–01
2021–07–25
2021–07–18
2021–07–11
2021–07–04
2021–06–27
2021–06–20
2021–06–13
2021–06–06
2021–05–30
2021–05–23
2021–05–16
2021–05–09
2021–05–02
2021–04–25
2021–04–18
2021–04–11
2021–04–04
2021–03–28
2021–03–21
2021–03–14
2021–03–07
2021–02–28
2021–02–21
2021–02–14
2021–02–07
2021–01–31
2021–01–24
2021–01–17
2021–01–10
2021–01–03
2020–12–27
2020–12–20
2020–12–13
2020–12–06
2020–11–29
2020–11–22
2020–11–15
2020–11–08
2020–11–01
2020–10–25
2020–10–18
2020–10–11
2020–10–04
2020–09–27
2020–09–20
2020–09–13
2020–09–06
Here are the seven most related reports.
 1. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meract“Metabolic reprogramming and anti-cancer therapy”, ∼ 14 p.p.i. ∼ 14 papers per issue
 2. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-imicid“Immunometabolism of infection, cancer and immune-mediated disease”, ∼ 32 p.p.i. ∼ 32 papers per issue
 3. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-medica“Metabolism and diet in cancer”, ∼ 21 p.p.i. ∼ 21 papers per issue
 4. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-camemi“Mitochondrial metabolism in cancer”, ∼ 48 p.p.i. ∼ 48 papers per issue
 5. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-meluca“Metabolism of non-small cell lung carcinoma”, ∼ 8 p.p.i. ∼ 8 papers per issue
 6. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-mibica“Mitochondrial bioenergetics in cancer”, ∼ 24 p.p.i. ∼ 24 papers per issue
 7. 
0000‒00‒00
 Signing up
0000‒00‒00
 Signed up
bims-celmim“Cellular and mitochondrial metabolism”, ∼ 21 p.p.i. ∼ 21 papers per issue
This page is being maintained by Thomas Krichel. It was last updated on 2026‒09‒27 at 11:08.